GlassScriptPhysician profile
Erika Correa
NPI 1720437346
$841.94
in general payments reported to CMS, 2019-2025
12 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.23 · 2021: $24.97 · 2022: $22.73 · 2023: $358 · 2024: $183 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $127.58 | 2023-2025 | |
| Daiichi Sankyo INC. | $124.13 | 2020-2025 | Injectafer |
| Lilly USA, LLC | $113.99 | 2023-2025 | Jaypirca, Verzenio, Retevmo |
| Pfizer INC. | $109.92 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $95.81 | 2023-2025 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $76.58 | 2024 | |
| Celgene Corporation | $66.04 | 2023 | Reblozyl |
| Genentech USA, INC. | $43.85 | 2023 | Polivy, Columvi, Lunsumio |
| Takeda Pharmaceuticals U.S.A., INC. | $25.44 | 2025 | Iclusig |
| Seagen INC. | $21.00 | 2023 | Padcev |
| Cti Biopharma Corp. | $20.00 | 2023 | Vonjo |
| Bayer Healthcare Pharmaceuticals INC. | $17.60 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.